Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Glanbia plc (GL9.IR)
Kilkenny, IE
Operating globally as a prominent nutrition company, Glanbia plc specializes in the development and distribution of sports and lifestyle nutrition products. These offerings come in various forms, including powdered supplements, ready-to-eat bars, convenient snacking foods, and prepared beverages. The company reaches consumers through a wide array of distribution channels, encompassing specialty retailers, online platforms, fitness centers, and larger retail environments such as food, drug, mass-market, and club stores. Additionally, Glanbia is a key producer of cheese, a diverse range of dairy and non-dairy nutritional and functional ingredients, and vital vitamin and mineral premixes. Its operational scope extends beyond product manufacturing to include activities such as financing, research and development, property management, receivables handling, general business administration, property leasing, various business services, and weight management solutions. The company boasts a robust portfolio of renowned brands, including OPTIMUM NUTRITION, SlimFast, BSN, ISOPURE, NUTRAMINO, think!, Amazing Grass, and BODY&FIT. Glanbia plc was founded in 1964 and maintains its corporate headquarters in Kilkenny, Ireland.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +2.05% | +5.46% | +19.20% | +41.04% | +42.97% | +62.97% | +53.72% | +52.26% | +24.02% | +1,667.80% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 6 | 0 |
| Hold | 3 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Packaged Foods: +4.4%+7.0% ★ Q4'25: -17.1% (vs Q4'23)
-
EPS growth Packaged Foods: +14.6%+21.0% ★ Q4'25: -37.0% (vs Q4'23)
-
FCF margin FCF growth · Packaged Foods: +15.9%+9.6% ★ Q4'25: +17.3% (vs Q4'23)
-
EBIT margin Packaged Foods: +7.9%+8.9% ★ Q4'25: +9.3% (vs Q4'23)
-
ROIC Packaged Foods: +7.0%+12.1% ★ Q4'25: +25.3% (vs Q4'23)
-
Share dilution Packaged Foods: +0.0%-4.6% ★ Q4'25: -6.5% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Packaged Foods: 0.19×2.33× Q4'25: 1.16× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 7 EPS Ana. |
Dec 2027 5 Rev. Ana. 8 EPS Ana. |
Dec 2028 4 Rev. Ana. 5 EPS Ana. |
Dec 2029 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.85B
est: 2.88B (-1.2%)
|
2.39B
est: 2.46B (-3.1%)
|
2.39B
est: 2.34B (+1.8%)
|
3.88B
est: 3.68B (+5.3%)
|
3.82B
est: 3.77B (+1.4%)
|
4.20B
est: 4.19B (+0.2%)
|
5.64B
est: 5.55B (+1.7%)
|
5.02B
est: 4.47B (+12.3%)
|
3.84B
est: 3.73B (+3.0%)
|
4.11B
est: 3.34B (+23.1%)
|
3.50B
3.46B – 3.54B
+4.8% YoY
|
3.62B
3.56B – 3.66B
+3.6% YoY
|
3.77B
3.72B – 3.82B
+4.1% YoY
|
3.93B
3.87B – 3.98B
+4.2% YoY
|
| EBITDA |
315.00M
est: 260.82M (+20.8%)
|
379.20M
est: 222.78M (+70.2%)
|
375.10M
est: 212.02M (+76.9%)
|
339.50M
est: 332.91M (+2.0%)
|
306.40M
est: 340.93M (-10.1%)
|
286.80M
est: 378.81M (-24.3%)
|
373.20M
est: 501.68M (-25.6%)
|
560.60M
est: 445.88M (+25.7%)
|
483.45M
est: 372.02M (+30.0%)
|
520.38M
est: 332.90M (+56.3%)
|
348.85M
344.70M – 353.49M
+4.8% YoY
|
361.47M
355.16M – 365.57M
+3.6% YoY
|
376.25M
370.71M – 380.88M
+4.1% YoY
|
392.03M
386.26M – 396.85M
+4.2% YoY
|
| EBIT |
236.40M
est: 177.99M (+32.8%)
|
320.20M
est: 152.03M (+110.6%)
|
327.39M
est: 144.68M (+126.3%)
|
254.22M
est: 227.18M (+11.9%)
|
186.89M
est: 232.65M (-19.7%)
|
159.90M
est: 258.50M (-38.1%)
|
230.70M
est: 342.35M (-32.6%)
|
411.60M
est: 312.96M (+31.5%)
|
384.38M
est: 261.12M (+47.2%)
|
365.52M
est: 233.66M (+56.4%)
|
244.86M
241.95M – 248.11M
+4.8% YoY
|
253.72M
249.29M – 256.59M
+3.6% YoY
|
264.09M
260.20M – 267.34M
+4.1% YoY
|
275.17M
271.11M – 278.55M
+4.2% YoY
|
| Net Income |
222.78M
est: 225.14M (-1.1%)
|
395.18M
est: 238.97M (+65.4%)
|
267.67M
est: 233.44M (+14.7%)
|
206.94M
est: 229.43M (-9.8%)
|
174.51M
est: 182.73M (-4.5%)
|
189.08M
est: 232.60M (-18.7%)
|
199.60M
est: 263.93M (-24.4%)
|
321.52M
est: 285.71M (+12.5%)
|
164.70M
est: 338.88M (-51.4%)
|
190.77M
est: 287.93M (-33.7%)
|
326.16M
317.51M – 334.82M
+13.3% YoY
|
348.94M
335.05M – 362.82M
+7.0% YoY
|
367.11M
362.16M – 441.84M
+5.2% YoY
|
418.71M
410.69M – 425.40M
+14.1% YoY
|
| SGA |
493.68M
est: 405.33M (+21.8%)
|
367.00M
est: 346.21M (+6.0%)
|
395.20M
est: 329.49M (+19.9%)
|
521.10M
est: 517.36M (+0.7%)
|
496.70M
est: 529.82M (-6.3%)
|
607.60M
est: 588.68M (+3.2%)
|
628.40M
est: 779.63M (-19.4%)
|
654.90M
est: 655.97M (-0.2%)
|
715.10M
est: 547.31M (+30.7%)
|
660.99M
est: 489.76M (+35.0%)
|
513.22M
507.12M – 520.04M
+4.8% YoY
|
531.79M
522.50M – 537.82M
+3.6% YoY
|
553.53M
545.38M – 560.34M
+4.1% YoY
|
576.75M
568.25M – 583.84M
+4.2% YoY
|
| EPS |
0.72
est: 0.85 (-15.2%)
|
1.12
est: 0.90 (+24.3%)
|
0.91
est: 0.88 (+3.4%)
|
0.61
est: 0.87 (-29.5%)
|
0.49
est: 0.69 (-28.9%)
|
0.58
est: 0.88 (-33.9%)
|
0.68
est: 1.00 (-31.7%)
|
1.18
est: 1.13 (+4.3%)
|
0.63
est: 1.34 (-53.0%)
|
0.76
est: 1.14 (-33.3%)
|
1.30
1.25 – 1.32
+14.2% YoY
|
1.39
1.32 – 1.43
+7.0% YoY
|
1.52
1.43 – 1.75
+9.1% YoY
|
1.65
1.62 – 1.68
+8.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-28 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-27 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-26 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-25 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-22 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-21 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-20 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-19 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-18 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-15 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-14 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-13 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-12 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-11 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-05 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-15 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hugh McGuire | Chief Executive Officer & Executive Director | 4M | male |
| Mark A. Garvey | Chief Financial Officer & Executive Director | 2M | male |
| Ian Doyle | Chief Corporate Development Officer | — | male |
| Jim Bergin | Chief Executive of Glanbia Ingredients Ireland Limited | — | male |
| Liam Hennigan | Group Secretary & Head of Investor Relations | — | male |
| Sorcha McKenna | Chief Strategy Officer | — | female |
| Steve Waters | Chief Supply Chain Officer | — | male |
| Tom Tench | CEO Dairy Nutrition | — | male |
| Aisling Zito | Chief Human Resources Officer | — | female |
| Wendy Smith | Chief Digital & Transformation Officer | — | female |
| Brian Phelan | Chief Executive Officer of Glanbia Nutritionals | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GL9.IR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
